Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers - Kaland ME, Klein-Schwartz W.
CONTEXT: Lisdexamfetamine is a pro-drug stimulant that requires the enzymatic hydrolysis of lysine from dexamphetamine for pharmacologic effects. There is limited information comparing non-therapeutic lisdexamfetamine and dextroamphetamine exposures. ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 10, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
New Binge-Eating Disorder Drug Vyvanse: FAQ
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 9, 2015 Category: Journals (General) Source Type: news
New Binge-Eating Disorder Drug Vyvanse: FAQ
The FDA has approved the first drug in the U.S. to treat binge-eating disorder, Vyvanse. The agency says it might lessen the number of food binges in people with the condition. (Source: WebMD Health)
Source: WebMD Health - February 4, 2015 Category: Consumer Health News Source Type: news
Monica Seles to help Shire ace marketing of new drug to treat binge-eating disorder
Analysts say that one of the biggest challenges Shire Pharmaceuticals will face in marketing the first-ever drug approved to treat binge-eating disorder is letting people know exactly what the disorder is. To that end, a partnership with former tennis star Monica Seles may help.
Last week, Shire announced its top-selling drug for attention-deficit hyperactivity disorder, Vyvanse, had earned additional approval from the U.S. Food and Drug Administration to treat binge eating, which is recognized… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 3, 2015 Category: Biotechnology Authors: Don Seiffert Source Type: news
FDA approves new drug for binge eating disorder (BED)
The United States Food and Drug Administration (FDA) recently approved lisdexamfetamine dimesylate, under the brand name Vyvanse, to treat moderate to severe binge eating disorder (BED) in adults, a first of its kind prescription drug specifically indicated for BED. Experts say that understanding the differences between obesity and BED is important for clinicians, as BED is an eating disorder that affects only a portion of those with the medical disease obesity. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 2, 2015 Category: Science Source Type: news
Vyvanse Approved for Binge-Eating Disorder
(Source: WebMD Health)
Source: WebMD Health - February 2, 2015 Category: Consumer Health News Source Type: news
Binge eating disorder drug made locally gets FDA approval
The Food and Drug Administration has approved Shire's application to market Vyvanse as a treatment for moderate-to-severe binge eating disorder in adults.
The drug is already approved for use in patients with attention deficit hyperactive disorder.
"Binge eating disorder is the most common adult eating disorder in the United States," said Philip J. Vickers, global head of research and development at Shire, in a prepared statement. "This new indication for Vyvanse is a critical milestone in the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 2, 2015 Category: Pharmaceuticals Authors: John George Source Type: news
Vyvanse Approved for Binge-Eating Disorder
Characterized by compulsive overeating
Source: HealthDay
Related MedlinePlus Pages: Eating Disorders, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 2, 2015 Category: Consumer Health News Source Type: news
First Drug Approved for Binge-Eating Disorder (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
Lisdexamfetamine dimesylate (Vyvanse), previously approved for treating attention-deficit hyperactivity disorder, is now approved to treat … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 2, 2015 Category: Primary Care Source Type: news
Vyvanse OK'd for Binge Eating
(MedPage Today) -- FDA gives green light for new indication for ADHD drug. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - January 31, 2015 Category: Pediatrics Source Type: news
Business Briefing: F.D.A. Approves a Drug for Binge-Eating Disorder
Federal health regulators have approved Vyvanse, an attention-deficit disorder drug, for a new use as a first-of-its kind treatment for binge-eating disorder. (Source: NYT Health)
Source: NYT Health - January 31, 2015 Category: Consumer Health News Authors: By THE ASSOCIATED PRESS Tags: Eating Disorders Drugs (Pharmaceuticals) Food and Drug Administration Source Type: news
FDA Okays Vyvanse for Binge Eating DisorderFDA Okays Vyvanse for Binge Eating Disorder
The FDA announced it has expanded the use of a drug approved for ADHD to treat binge eating disorder. News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2015 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news
FDA approves Shire's Vyvanse for binge-eating disorder
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
FDA expands uses of Vyvanse to treat binge-eating disorder
The U.S. Food and Drug Administration today expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults. The drug is the first FDA-approved medication to treat this condition. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 30, 2015 Category: American Health Source Type: news
This Week: Tavenner Out at CMS, Vyvanse Promising for Binge Eating
(MedPage Today) -- Top medical stories during the week of Jan. 12. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 16, 2015 Category: Psychiatry Source Type: news
